Skip to content
Colorectal Cancer Clinical Trials

Florida

Colorectal cancer clinical trials in Florida

132 colorectal cancer studies are recruiting participants at sites in 62 cities across Florida as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse Florida by city

Cities with the most studies recruiting right now.

Every Florida city with a recruiting study

Tampa (41), Jacksonville (29), Orlando (23), Miami (21), Sarasota (17), Gainesville (13), St. Petersburg (12), Fort Myers (10), Celebration (6), Fort Lauderdale (6), Plantation (6), Coral Springs (5), Hollywood (5), Lakeland (5), Miami Beach (5), Tamarac (5), West Palm Beach (5), Aventura (3), Bonita Springs (3), Clearwater (3), Deerfield Beach (3), Doral (3), Hialeah (3), Plant City (3), Winter Haven (3), Cape Coral (2), Coral Gables (2), Lake Mary (2), Margate (2), N. Venice (2), Ocala (2), Orange City (2), Port Charlotte (2), Port Saint Lucie (2), Weston (2), Altamonte Springs (1), Bay Pines (1), Boca Raton (1), Boynton Beach (1), Bradenton (1), Brandon (1), Daytona Beach (1), DeLand (1), Delray Beach (1), Florida City (1), Kissimmee (1), Largo (1), Melbourne (1), Naples (1), North Miami (1), Palm Bay (1), Palm Coast (1), Palm Harbor (1), Pembroke Pines (1), Pensacola (1), Reunion (1), Rockledge (1), Safety Harbor (1), Tallahassee (1), Trinity (1), Wesley Chapel (1), Winter Park (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Florida

Basic details from each study's public record (the 12 most recently updated of 132). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Aventura · Coral Gables · Deerfield Beach · and 3 more U.S. locations
    Registry record
    NCT05863195 · updated
  2. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Recruiting in
    Lakeland · Tampa
    Registry record
    NCT06324357 · updated
  3. A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 to 99
    • All sexes
    Sponsor
    Erasca, Inc.
    Recruiting in
    Sarasota · Tampa
    Registry record
    NCT06983743 · updated
  4. Study of Petosemtamab Plus Chemotherapy Versus Cetuximab or Bevacizumab Plus Chemotherapy in RAS and BRAF Wild Type, Recurrent, Unresectable or Metastatic Colorectal Cancer (LiGeR-CRC2)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Genmab
    Recruiting in
    Tampa
    Registry record
    NCT07775287 · updated
  5. Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses

    • No phase
    • Ages 22 and older
    • All sexes
    Sponsor
    GI Windows, Inc.
    Recruiting in
    Orlando
    Registry record
    NCT07276529 · updated
  6. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Recruiting in
    Miami
    Registry record
    NCT07488676 · updated
  7. Shield Post-Approval Study Protocol

    • Observational
    • Ages 45 to 81
    • All sexes
    Sponsor
    Guardant Health, Inc.
    Recruiting in
    Boca Raton · Delray Beach · Doral · and 4 more U.S. locations
    Registry record
    NCT06880055 · updated
  8. A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Fort Myers · Jacksonville · Orlando · and 2 more U.S. locations
    Registry record
    NCT06997497 · updated
  9. A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kestrel Therapeutics, Inc.
    Recruiting in
    Sarasota · Tampa
    Registry record
    NCT07458347 · updated
  10. A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Recruiting in
    Coral Springs · Tamarac · Tampa
    Registry record
    NCT07659795 · updated
  11. Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Exelixis
    Recruiting in
    Fort Lauderdale · Lake Mary · Orlando
    Registry record
    NCT07750158 · updated
  12. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Recruiting in
    Celebration · Plantation · Sarasota
    Registry record
    NCT07503808 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Florida on ClinicalTrials.gov.

Ask about studies in Florida

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call